SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 96.29 |
Enterprise Value ($M) | 90.28 |
Book Value ($M) | 132.15 |
Book Value / Share | 1.39 |
Price / Book | 0.73 |
NCAV ($M) | 30.56 |
NCAV / Share | 0.32 |
Price / NCAV | 3.15 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.00 |
Return on Assets (ROA) | -0.91 |
Return on Equity (ROE) | -1.79 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.51 |
Current Ratio | 1.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 177.85 |
Assets | 279.44 |
Liabilities | 147.29 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 4.68 | -8.37 | |
13G/A | BlackRock Inc. | 1.50 | -78.92 | |
13G/A | Continental General Insurance Co | 0.00 | -100.00 | |
13G/A | Armistice Capital, Llc | 6.13 | ||
13G | Nantahala Capital Management, LLC | 8.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,144,238 | 4,395,167 | 26.03 | |
99,456 | 317,363 | 31.34 | |
172,241 | 630,049 | 27.34 | |
210,359 | 532,789 | 39.48 | |
(click for more detail) |
Similar Companies | |
---|---|
APVO – Aptevo Therapeutics Inc. | ARTL – Artelo Biosciences, Inc. |
ASNS – Actelis Networks, Inc. | ATNF – 180 Life Sciences Corp. |
ATOS – Atossa Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io